Altogether, these results provide for the first time evidence that both MGL- and MGL1-expressing APCs might play a role in limiting the inflammatory response by fostering an anti-inflammatory environment in MS or EAE by increasing IL-10 secretion and inducing apoptosis of effector T cells. The gene discussed is CLEC10A; the disease is myeloid sarcoma.